Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Medistim

Director's Dealing • Nov 20, 2024

3662_dirs_2024-11-20_d229cc70-1ae7-48c9-b9cf-dd767ee74182.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Notification of trade in the Medistim share

Notification of trade in the Medistim share

Tore Krogstad, related party to Medistim’s CEO Kari Krogstad, has purchased through the company Engelia Invest AS 1500 shares in Medstim ASA the 20th of November. The average price per share purchased was NOK 139.77. After the purchase, Engelia Invest AS holds 1500 Medistim shares.

More from Medistim

Director's Dealing 2025
Nov 11
Director's Dealing 2025
Nov 10
Investor Presentation 2025
Oct 24
Earnings Release 2025
Oct 24
Earnings Release 2025
Oct 24
Report Publication Announcement 2025
Oct 17
Major Shareholding Notification 2025
Sep 12
Interim / Quarterly Report 2025
Aug 20
Investor Presentation 2025
Aug 20
Earnings Release 2025
Aug 20
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.